Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
about
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart FailureTargeting interleukin-1 in heart diseaseDid Dumbo suffer a heart attack? independent association between earlobe crease and cardiovascular disease.Inflammatory markers in ST-elevation acute myocardial infarction.Systemic inflammatory response following acute myocardial infarctionInterleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational conceptsL5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages.Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications.Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1β Production.VCP746, a novel A1 adenosine receptor biased agonist, reduces hypertrophy in a rat neonatal cardiac myocyte model.Effects of rhBNP on myocardial fibrosis after myocardial infarction in rats.Antiarrhythmic effects of interleukin 1 inhibition after myocardial infarction.Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition
P2860
Q26753845-A3FDC21D-58CF-4D4B-9F8F-80CC224A1C14Q27009347-D6FBB0CD-2114-4887-B8F2-B2DA6AD00D1AQ35899244-A9A4410D-AFCE-4272-AC68-AE258C910075Q38355385-9ECCF3F9-8DBE-4152-8F9B-BBCCE47BDF16Q38531965-0AB7EF96-B696-4F8C-8BAF-DE58A45551CCQ38566665-06B47FC3-FA16-452B-88EE-D3F738B8515EQ38730205-738C1667-EA48-496E-A519-2DA841EF8FA7Q39223572-603A69B1-889C-4D49-A072-FB10E7F412EAQ40479886-0656CBA8-4437-4F34-AE5A-D454B90F40EEQ40667527-2A1152B4-189C-4F5C-AF82-7BAFFF5625D4Q42418432-F95D3E19-1809-4B18-BB7E-23DDD8B619E3Q46173512-0CB66D76-ECA5-4A8E-91E6-E3C51F01F6A5Q47734765-0F3FB614-9CC2-4F8D-9F90-4AFE17AA60A7Q50560471-EDC76650-A854-41D4-9F09-95CFA5371264Q52730911-6B566AF5-0A1D-4B4F-8BD2-D3C67E694BD0Q57162899-A652E33D-CC55-4338-9C07-5B90CB6BAD8E
P2860
Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Increased interleukin-1β level ...... taneous coronary intervention.
@en
Increased interleukin-1β level ...... taneous coronary intervention.
@nl
type
label
Increased interleukin-1β level ...... taneous coronary intervention.
@en
Increased interleukin-1β level ...... taneous coronary intervention.
@nl
prefLabel
Increased interleukin-1β level ...... taneous coronary intervention.
@en
Increased interleukin-1β level ...... taneous coronary intervention.
@nl
P2093
P2860
P50
P1476
Increased interleukin-1β level ...... taneous coronary intervention.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2012.02517.X
P407
P577
2012-02-26T00:00:00Z